Key result
Anti-inflammatory cytokines like IL-35 inhibit endothelial dysfunction, highlighting novel therapeutic targets for cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
Review reveals how anti-inflammatory cytokines suppress endothelial dysfunction, highlighting novel therapeutic targets for cardio- and cerebrovascular diseases.
Endothelial dysfunction is a pathological status of the vascular system, which can be broadly defined as an imbalance between endothelium-dependent vasoconstriction and vasodilation. Endothelial dysfunction is a key event in the progression of many pathological processes including atherosclerosis, type II diabetes and hypertension. Previous reports have demonstrated that pro-inflammatory/immunoeffector cytokines significantly promote endothelial dysfunction while numerous novel anti-inflammatory/immunosuppressive cytokines have recently been identified such as interleukin (IL)-35. However, the effects of anti-inflammatory cytokines on endothelial dysfunction have received much less attention. In this analytical review, we focus on the recent progress attained in characterizing the direct and indirect effects of anti-inflammatory/immunosuppressive cytokines in the inhibition of endothelial dysfunction. Our analyses are not only limited to the importance of endothelial dysfunction in cardiovascular disease progression, but also expand into the molecular mechanisms and pathways underlying the inhibition of endothelial dysfunction by anti-inflammatory/immunosuppressive cytokines. Our review suggests that anti-inflammatory/immunosuppressive cytokines serve as novel therapeutic targets for inhibiting endothelial dysfunction, vascular inflammation and cardio- and cerebro-vascular diseases.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2014) conducted a review in Endothelial dysfunction and cardiovascular disease. Anti-inflammatory/immunosuppressive cytokines (e.g., interleukin-35) vs. Pro-inflammatory/immunoeffector cytokines was evaluated on Inhibition of endothelial dysfunction and vascular inflammation. Anti-inflammatory and immunosuppressive cytokines such as IL-35 directly and indirectly inhibit endothelial dysfunction and represent novel therapeutic targets for cardiovascular diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: